about
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reu...
Read More
2.71
0.09
(3.44%)
32,647
XNAS Volume
High vol. this week
XNAS 11 Mar, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
NLS Pharmaceutics Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..